Choate represented Transformation Capital in the transaction, while Cuatrecasas represented Vesalius Biocapital III Partners. SWORD Health closed a $25M Series B financing, in which Transformation Capital acted…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now